Login to Your Account



Biogen Reports Strong 2Q; Avonex Sales Beat Estimates

By Peter Winter
BioWorld Insight Editor

Wednesday, August 8, 2012

Biogen Idec Inc. soundly beat earnings estimates for the quarter by more than 16 percent. The company reported adjusted net income of $1.82 per share and Wall Street was looking for $1.56 per share.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription